We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Prokarium Announces MHRA Acceptance To Run Phase I Trial of Enteric Fever Vaccine

Product News   Nov 26, 2019

 
Prokarium Announces MHRA Acceptance To Run Phase I Trial of Enteric Fever Vaccine
FURTHER INFORMATION
 
 
Advertisement
 

Related Product News

New Collaboration Aims to Increase COVID-19 Reagent Production

Product News

OXGENE™ and The Native Antigen Company have announced a collaboration to scale up their antigen manufacturing capabilities to deliver high-purity, recombinant proteins for the development of diagnostics and vaccines.

READ MORE

StemFit® Feeder Free Medium ES/iPS Cell Culture

Product News

AMSBIO report on a world-first clinical study of iPSC-derived corneal epithelial cells using StemFit Basic03 clinical grade stem cell culture medium and iMatrix-511 recombinant laminin E8 fragments.

READ MORE

Developing a COVID-19 Vaccine: Cobra Biologics Part of ChAdOx1 Consortium

Product News

Cobra Biologics has announced it is working as part of a consortium led by the Jenner Institute, Oxford University to rapidly develop, scale-up and produce the potential adenoviral vaccine candidate, ChAdOx1 nCov-19 (ChAdOx1), for fast-tracked clinical trials for COVID-19.

READ MORE

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE